Skip to content

Effectiveness of Yoga Practices on Depression and Anxiety Levels in Chronic Kidney Disease Patients

The Influence of Yoga Practices on Depression and Anxiety Levels in Chronic Kidney Disease Patients: A Pilot Study - nil

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/063444
Enrollment
10
Registered
2024-03-01
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N189- Chronic kidney disease, unspecified

Interventions

Intervention1: Yoga practice along with usual treatment: Intervention will be given by a certified Yoga instructor and usual treatment by qualified doctors. Patients will perform Regular 50 min to 1-h

Sponsors

J S Ayurveda Mahavidyalaya and P D Patel Ayurveda Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Those between 18 and 80 years of age, who gave written informed consent, and who were mentally and physically fit up to a minimum level to understand and perform yoga practices were included. CKD patients under treatment (both non-dialysis and undergoing dialysis) CKD patients with diabetes type 2/ hypertension controlled with medications CKD patients are advised to continue their present medications as prescribed by the doctor. Yoga practices will be added as complimentary along with medications. Participants were told to practice yoga regularly for at least 6 days a week for 50–60 min a day. All Yoga practices are not mandatory, if the patient is not able to do it.

Exclusion criteria

Exclusion criteria: Those aged less than 18 years and above 80 years. Individuals with ischemic heart disease, post-coronary artery bypass grafting, comorbid coronary artery disease, single working kidney, congenital renal malformations, or a history of past carcinoma are excluded from the study. Either anxiety and depression questionnaire or any one among anxiety or depression questionnaire should be diagnosed positive with the respective questionnaire 1. Hamilton Anxiety Rating Scale (HAM-A)-Patients scoring 0 score while using the questionnaire should be excluded 2. PHQ-9 Patient Depression Questionnaire - If the combined score for the -very difficult/extremely difficult- (grades 2 or 3) is fewer than 2 ticks should be excluded

Design outcomes

Primary

MeasureTime frame
Change in depression levelTimepoint: baseline, after 21 days of intervention

Secondary

MeasureTime frame
Change in anxiety levelTimepoint: baseline, after 21 days of intervention

Countries

India

Contacts

Public ContactDr Praveen Suthar

Faculty of Medicine, Parul Institute of Public Health, Parul University, Vadodara

praveen.suthar24605@paruluniversity.ac.in9460248139

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026